The primary and most widely recognized brand name under which Cipla manufactures and markets paracetamol is Paracip, available in various dosage strengths including 500 milligrams and 650 milligrams. Paracip is extensively prescribed and purchased over the counter across multiple international markets as a trusted first-line treatment for reducing fever, managing mild-to-moderate headaches, alleviating muscle aches, and easing general body discomfort. The product is distributed in diverse pharmaceutical forms, such as oral tablets, syrups, dispersible formulations, and intravenous infusions, ensuring versatile administration options for clinical environments and home healthcare settings.